UK Markets open in 1 hr 11 mins
  • NIKKEI 225

    27,522.26
    -250.64 (-0.90%)
     
  • HANG SENG

    24,965.55
    +13.25 (+0.05%)
     
  • CRUDE OIL

    0 (0)
     
  • GOLD FUTURES

    1,841.10
    -0.60 (-0.03%)
     
  • DOW

    34,364.50
    +99.10 (+0.29%)
     
  • BTC-GBP

    26,692.74
    +373.00 (+1.42%)
     
  • CMC Crypto 200

    823.79
    +13.18 (+1.63%)
     
  • Nasdaq

    13,855.13
    +86.23 (+0.63%)
     
  • ^FTAS

    4,217.31
    -57.21 (-1.34%)
     

Insights on the Clinical Trial Supply & Logistics for Pharmaceutical Global Market to 2026 - Featuring Bilcare, Catalent and Marken Among Others

·7-min read

Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase, Sector, Therapeutic Area, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 18,213.74 million in 2020, is expected to reach USD 19,607.86 million in 2021, and projected to grow at a CAGR of 7.68% reaching USD 28,394.99 million by 2026.

Market Statistics

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics for Pharmaceutical to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Phase, the market was studied across BA/BE Studies, Phase I, Phase II, Phase III, and Phase IV.

  • Based on Sector, the market was studied across Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management.

  • Based on Therapeutic Area, the market was studied across Blood Disorders, Digestive System Diseases, Infectious and Immune System Diseases, Neurological and Mental Disorders, and Oncology.

  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market, including Almac Group, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Metrics Contract Services by Mayne Pharma group, Movianto, N-Side, Parexel International Corporation, PRA Health Sciences, Inc., Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., UDG Healthcare PLC, and World Courier Management Inc.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Supply & Logistics for Pharmaceutical Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
6. What is the market share of the leading vendors in the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Supply & Logistics for Pharmaceutical Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
5.2.2. Increased Focus on Drug Development
5.2.3. Globalization of Clinical Trials and Harmonization of Regulations
5.3. Restraints
5.3.1. Increased Cost of Drug Development and Clinical Trials
5.4. Opportunities
5.4.1. Outsourcing of Clinical Trial Activity
5.4.2. Increased Focus on Generics and Biologics
5.4.3. Regulatory Approvals in Emerging Markets
5.5. Challenges
5.5.1. Logistics Challenges across Nations

6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
6.1. Introduction
6.2. BA/BE Studies
6.3. Phase I
6.4. Phase II
6.5. Phase III
6.6. Phase IV

7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector
7.1. Introduction
7.2. Clinical Trial Logistics and Distributions
7.3. Clinical Trial Manufacturing Services
7.4. Clinical Trial Supply Chain Management

8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Digestive System Diseases
8.4. Infectious and Immune System Diseases
8.5. Neurological and Mental Disorders
8.6. Oncology

9. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Quadrant
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Almac Group
13.2. Bilcare Limited
13.3. Biocair International Limited
13.4. Catalent, Inc.
13.5. Clinigen Group PLC
13.6. DHL International GmbH by Deutsche Post AG
13.7. Eurofins Scientific SE
13.8. FedEx Corporation
13.9. Infosys Limited
13.10. KLIFO A/S
13.11. Lonza Group
13.12. Marken
13.13. Metrics Contract Services by Mayne Pharma group
13.14. Movianto
13.15. N-Side
13.16. Parexel International Corporation
13.17. PRA Health Sciences, Inc.
13.18. Seveillar Clinical Trial Supplies Pvt. Ltd.
13.19. SIRO Clinpharm Private Limited
13.20. Thermo Fisher Scientific, Inc.
13.21. UDG Healthcare PLC
13.22. World Courier Management Inc.

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/gpkbl0

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting